scholarly journals Comments on the value International Prognostic Score (IPS), stage IV and age over 45 years, for the outcome of advanced Hodgkin lymphoma in chemotherapy containing adriamycin. The experience of the Spanish Hodgkin Lymphoma Study Group

2016 ◽  
Vol 178 (2) ◽  
pp. 336-338 ◽  
Author(s):  
Pablo Guisado-Vasco ◽  
Carlos Montalban ◽  
Juan F. García ◽  
Keyword(s):  
Hodgkin Lymphoma ◽  
Prognostic Score ◽  
Stage Iv ◽  
Study Group ◽  
International Prognostic Score ◽  
Lymphoma Study Group

Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages

2016 ◽  
Vol 57 (8) ◽  
pp. 1839-1847 ◽  
Author(s):  
Ljubomir R. Jakovic ◽  
Biljana S. Mihaljevic ◽  
Bosko M. Andjelic ◽  
Andrija D. Bogdanovic ◽  
Maja D. Perunicic Jovanovic ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Prognostic Value ◽  
Prognostic Score ◽  
Tumor Associated Macrophages ◽  
International Prognostic Score

Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group.

1995 ◽  
Vol 13 (2) ◽  
pp. 403-409 ◽  
Author(s):  
R Munker ◽  
D Hasenclever ◽  
O Brosteanu ◽  
E Hiller ◽  
V Diehl
Keyword(s):  
Bone Marrow ◽  
Hodgkin's Disease ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin’S Disease ◽  
Bone Marrow Involvement ◽  
Stage Iv ◽  
Hodgkin's Lymphoma ◽  
Study Group ◽  
Prognostic Relevance ◽  
Lymphoma Study Group

PURPOSE To describe the incidence of primary bone marrow involvement (BMI) in Hodgkin's disease (HD) and its correlation with clinical and laboratory features present at diagnosis, and to evaluate the prognostic relevance of BMI. PATIENTS AND METHODS Between 1983 and 1991, 2,307 patients with HD were treated according to two trial generations (HD1-3 and HD4-6) of the German Hodgkin's Lymphoma Study Group (GHSG). RESULTS One hundred thirty-five cases of primary BMI were observed. The incidence of BMI was 4.8% in the HD4-6 study generation, which included all stages. Among stage IV patients, 32% had BMI. Among those with BMI, other organs were also involved in 33%. Among all patients, the presence of BMI was significantly associated with B symptoms, lymph nodes on both sides of the diaphragm, mixed cellularity histologic subtype, leukocytopenia, anemia, thrombocytopenia, lactate dehydrogenase (LDH) level more than 400 U/L, and erythrocyte sedimentation rate (ESR) more than 40 mm/h. BMI was negatively correlated with a large mediastinal tumor (3.7% v 20.0% in non-BMI cases). Eighty-seven of 108 (81%) assessable patients with BMI achieved a complete remission (CR). This compares favorably with the overall CR rate in all stage IIIB/IV patients. Among stage IV patients, BMI has no prognostic relevance with regard to freedom from treatment failure and overall survival. Twenty-one patients with BMI relapsed after having achieved a CR. Only five of these (24%) again had a positive bone marrow biopsy. CONCLUSION The prognosis of patients with BMI is not worse than the prognosis of other advanced-stage HD patients. BMI alone does not define a special high-risk group in which a different treatment approach is indicated.

scholarly journals Erratum: Improved treatment results of children with B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study

2014 ◽  
Vol 61 (11) ◽  
pp. 2144-2144
Author(s):  
Masahito Tsurusawa ◽  
Tetsuya Mori ◽  
Akira Kikuchi ◽  
Tetsuo Mitsui ◽  
Shosuke Sunami ◽  
...  
Keyword(s):  
B Cell ◽  
Hodgkin Lymphoma ◽  
Study Group ◽  
Treatment Results ◽  
Pediatric Leukemia ◽  
Non Hodgkin Lymphoma ◽  
Lymphoma Study Group ◽  
Group B

Diffuse Large B-cell Lymphoma Arising in Nodular Lymphocyte Predominant Hodgkin Lymphoma. A Report of 21 Cases from the Nebraska Lymphoma Study Group

2003 ◽  
Vol 44 (11) ◽  
pp. 1903-1910 ◽  
Author(s):  
James Z. Huang ◽  
Dennis D. Weisenburger ◽  
Julie M. Vose ◽  
Timothy C. Greiner ◽  
Patricia Aoun ◽  
...  
Keyword(s):  
B Cell ◽  
Hodgkin Lymphoma ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Study Group ◽  
Large B Cell Lymphoma ◽  
Lymphoma Study Group ◽  
Large B Cell

Fertility in male patients with Hodgkin's disease after therapy –results from the German Hodgkin Lymphoma Study Group (GHSG)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 6547-6547
Author(s):  
M. Sieniawski ◽  
A. Josting ◽  
K. Breuer ◽  
T. Sven ◽  
V. Diehl ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Study Group ◽  
Male Patients ◽  
Lymphoma Study Group
Sign in / Sign up

Export Citation Format

Share Document